Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study

[1]  A. Della Rossa,et al.  Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study , 2019, Clinical and Experimental Medicine.

[2]  M. Bocchino,et al.  Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early–early systemic sclerosis): a TDI study , 2018, Clinical and Experimental Medicine (Testo stampato).

[3]  Y. Asano,et al.  Association of anti‐RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis , 2016, The Journal of dermatology.

[4]  M. Roustit,et al.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers. , 2016, British journal of clinical pharmacology.

[5]  S. Negrini,et al.  Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients , 2016, Clinical and Experimental Medicine.

[6]  Yong-Beom Park,et al.  Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud’s phenomenon , 2015, Arthritis Research & Therapy.

[7]  M. Doherty,et al.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies , 2015, BMJ Open.

[8]  A. Psarras,et al.  Systemic Sclerosis and Silicone Breast Implant: A Case Report and Review of the Literature , 2014, Case reports in rheumatology.

[9]  F. Perosa,et al.  Raynaud's phenomenon: from molecular pathogenesis to therapy. , 2014, Autoimmunity reviews.

[10]  G. Naughton,et al.  The long-term effects of occupational exposure to vinyl chloride monomer on microcirculation: a cross-sectional study 15 years after retirement , 2013, BMJ Open.

[11]  M. Goldberg,et al.  Risk factors for Raynaud's phenomenon in the workforce , 2012, Arthritis care & research.

[12]  K. Ikeda,et al.  A Longitudinal Study on Raynaud's Phenomenon in Workers Using an Impact Wrench , 2012, Journal of occupational health.

[13]  A. Harrison,et al.  Raynaud’s Phenomenon in Medical Laboratory Workers Who Work with Solvents , 2011, The Journal of Rheumatology.

[14]  Tohr Nilsson,et al.  White fingers, cold environment, and vibration--exposure among Swedish construction workers. , 2010, Scandinavian journal of work, environment & health.

[15]  S. Khuder,et al.  Occupational silica exposure as a risk factor for scleroderma: a meta-analysis , 2010, International archives of occupational and environmental health.

[16]  C. Goulvestre,et al.  Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse1 , 2009, The Journal of Immunology.

[17]  J. Murabito,et al.  Smoking, alcohol consumption, and Raynaud's phenomenon in middle age. , 2007, The American journal of medicine.

[18]  F. Salaffi,et al.  Raynaud's phenomenon: prevalence in an Italian population sample , 2006, Clinical Rheumatology.

[19]  M J Griffin,et al.  Prevalence and pattern of occupational exposure to whole body vibration in Great Britain: findings from a national survey , 2000, Occupational and environmental medicine.

[20]  C. Papanikolaou,et al.  Prevalence of Raynaud's phenomenon in a healthy Greek population , 2000, Annals of the rheumatic diseases.

[21]  Y. Palesch,et al.  Association between cigarette and alcohol consumption and Raynaud's phenomenon. , 1999, Journal of clinical epidemiology.

[22]  P. Wilson,et al.  Different factors influencing the expression of Raynaud's phenomenon in men and women. , 1999, Arthritis and rheumatism.

[23]  H. Spiera,et al.  Silicone gel filled breast implants and connective tissue disease: an overview. , 1994, The Journal of rheumatology.

[24]  N. Tsapatsaris,et al.  Association between Raynaud's phenomenon and migraine in a random population of hospital employees. , 1993, The Journal of rheumatology.

[25]  M. Vilardell,et al.  Prevalence of Raynaud's phenomenon in a healthy Spanish population. , 1993, The Journal of rheumatology.

[26]  C. van Weel,et al.  Prevalence of Raynaud's phenomenon. , 1992, The Netherlands journal of medicine.

[27]  M. Weinrich,et al.  Demographic, social and clinical correlates of Raynaud phenomenon. , 1991, International journal of epidemiology.

[28]  A. Silman,et al.  Prevalence of symptoms of Raynaud's phenomenon in general practice. , 1990, BMJ.

[29]  V. C. Roberts,et al.  An epidemiological survey of Raynaud's phenomenon. , 1988, European journal of vascular surgery.

[30]  K. Miyashita,et al.  [Prevalence of Raynaud's phenomenon in individuals not using vibrating tools]. , 1987, Sangyo igaku. Japanese journal of industrial health.

[31]  M. Weinrich,et al.  Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. , 1986, Journal of chronic diseases.